Therapeutic potential of neuropeptide Y (NPY) receptor ligands

por Brothers, Shaun P, Wahlestedt, Claes
Publicado 2010

Naturally occurring compounds as pancreatic cancer therapeutics

por Lohse, Ines, Wildermuth, Erin, Brothers, Shaun P.
Publicado 2018

mRNA-to-protein translation in hypoxia

por Chee, Nancy T., Lohse, Ines, Brothers, Shaun P.
Publicado 2019

Emerging treatment strategies for glioblastoma multiforme

por Carlsson, Steven K, Brothers, Shaun P, Wahlestedt, Claes
Publicado 2014

Oxytocin and social functioning

por Jones, Candace, Barrera, Ingrid, Brothers, Shaun, Ring, Robert, Wahlestedt, Claes
Publicado 2017

Precision medicine in the treatment stratification of AML patients: challenges and progress

por Lohse, Ines, Statz-Geary, Kurt, Brothers, Shaun P., Wahlestedt, Claes
Publicado 2018

Activating transcription factor 4 regulates hypoxia inducible factor 1α in chronic hypoxia in pancreatic cancer cells

por Chee, Nancy T., Carriere, Candace H., Miller, Zachary, Welford, Scott, Brothers, Shaun P.
Publicado 2022

A Novel RNA Transcript with Antiapoptotic Function Is Silenced in Fragile X Syndrome

por Khalil, Ahmad M., Faghihi, Mohammad Ali, Modarresi, Farzaneh, Brothers, Shaun P., Wahlestedt, Claes
Publicado 2008

Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL (TM))

por Kemper, Christopher, Behnam, Dariush, Brothers, Shaun, Wahlestedt, Claes, Volmar, Claude-Henry, Bennett, Daniel, Hayward, Marshall
Publicado 2022

The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models

por Aziz, Abdul Maruf Asif, Brothers, Shaun, Sartor, Gregory, Holm, Lovisa, Heilig, Markus, Wahlestedt, Claes, Thorsell, Annika
Publicado 2016

Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients

por Dennison, Jessica L., Al-Ali, Hassan, Volmar, Claude-Henry, Brothers, Shaun, Watts, Justin, Wahlestedt, Claes, Lohse, Ines
Publicado 2022

Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma

por Lohse, Ines, Al-Ali, Hassan, Volmar, Claude-Henry, D. Alvarez Trotta, Annamil, Brothers, Shaun P., Capobianco, Anthony J., Wahlestedt, Claes
Publicado 2018

Inhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model

por Janczura, Karolina J., Volmar, Claude-Henry, Sartor, Gregory C., Rao, Sunil J., Ricciardi, Natalie R., Lambert, Guerline, Brothers, Shaun P., Wahlestedt, Claes
Publicado 2018

RNAi Screen Indicates Widespread Biological Function for Human Natural Antisense Transcripts

por Faghihi, Mohammad Ali, Kocerha, Jannet, Modarresi, Farzaneh, Engström, Pär G., Chalk, Alistair M., Brothers, Shaun P., Koesema, Eric, St. Laurent, Georges, Wahlestedt, Claes
Publicado 2010

Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1

por GALOIAN, KARINA, QURESHI, AMIR, D’IPPOLITO, GIANLUCA, SCHILLER, PAUL C., MOLINARI, MARCO, JOHNSTONE, ANDREA L., BROTHERS, SHAUN P., PAZ, ANA C., TEMPLE, H.T.
Publicado 2015

HDAC Inhibitors Induce BDNF Expression and Promote Neurite Outgrowth in Human Neural Progenitor Cells-Derived Neurons

por Bagheri, Amir, Habibzadeh, Parham, Razavipour, Seyedeh Fatemeh, Volmar, Claude-Henry, Chee, Nancy T., Brothers, Shaun P., Wahlestedt, Claes, Mowla, Seyed Javad, Faghihi, Mohammad Ali
Publicado 2019

Natural Antisense Inhibition Results in Transcriptional De-Repression and Gene Upregulation

por Modarresi, Farzaneh, Faghihi, Mohammad Ali, Lopez-Toledano, Miguel A., Fatemi, Roya Pedram, Magistri, Marco, Brothers, Shaun P., van der Brug, Marcel P., Wahlestedt, Claes
Publicado 2012

A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer

por Khalafi, Shayan, Zhu, Shoumin, Khurana, Rimpi, Lohse, Ines, Giordano, Silvia, Corso, Simona, Al-Ali, Hassan, Brothers, Shaun P., Wahlestedt, Claes, Schürer, Stephan, El-Rifai, Wael
Publicado 2021

Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer

por Mustafi, Sushmita, Camarena, Vladimir, Qureshi, Rehana, Yoon, Hyunho, Volmar, Claude-Henry, Huff, Tyler C., Sant, David W., Zheng, Lihong, Brothers, Shaun P., Wahlestedt, Claes, Slingerland, Joyce, Wang, Gaofeng
Publicado 2019

BET bromodomain proteins are required for glioblastoma cell proliferation

por Pastori, Chiara, Daniel, Mark, Penas, Clara, Volmar, Claude-Henry, Johnstone, Andrea L, Brothers, Shaun P, Graham, Regina M, Allen, Bryce, Sarkaria, Jann N, Komotar, Ricardo J, Wahlestedt, Claes, Ayad, Nagi G
Publicado 2014